Cargando…
A population pharmacokinetic model of remdesivir and its major metabolites based on published mean values from healthy subjects
Remdesivir is a direct-acting anti-viral agent. It was originally evaluated against filoviruses. However, during the COVID-19 pandemic, it was investigated due to its anti-viral activities against (SARS-CoV-2) virus. Therefore remdesivir received conditional approval for treatment of patients with s...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9485022/ https://www.ncbi.nlm.nih.gov/pubmed/36123499 http://dx.doi.org/10.1007/s00210-022-02292-6 |